Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Neurogene
NGNE
$729M
| $53.4K | ﹤0.01% |
3,575
-5,001
| -58% | -$78.5K |
|
4552
Blue Owl Capital
OBDC
$5.7B
| $53.3K | ﹤0.01% |
3,714
-36,467
| -91% | -$518K |
|
|
ALMU
4553
Aeluma Inc
ALMU
$316M
| $53.2K | ﹤0.01% |
+3,250
| New | +$39K |
|
4554
Capital Group Growth ETF
CGGR
$25B
| $53.2K | ﹤0.01% |
+1,308
| New | +$47.7K |
|
|
NPB
4555
Northpointe Bancshares
NPB
$588M
| $53.1K | ﹤0.01% |
+3,876
| New | +$52.1K |
|
|
LNKB
4556
DELISTED
LINKBANCORP
LNKB
| $53.1K | ﹤0.01% |
7,269
-8,064
| -53% | -$55.3K |
|
4557
Citizens
CIA
$194M
| $53K | ﹤0.01% |
15,172
-5,229
| -26% | -$20.4K |
|
4558
GrafTech
EAF
$205M
| $52.9K | ﹤0.01% |
5,441
-13,280
| -71% | -$117K |
|
4559
MediWound
MDWD
$178M
| $52.8K | ﹤0.01% |
2,728
-6,098
| -69% | -$115K |
|
|
ZBIO
4560
Zenas BioPharma
ZBIO
$2.02B
| $52.8K | ﹤0.01% |
5,451
-5,359
| -50% | -$52.2K |
|
4561
Entravision Communication
EVC
$1.08B
| $52.6K | ﹤0.01% |
22,667
-20,223
| -47% | -$40.8K |
|
4562
Sibanye-Stillwater
SBSW
$7.55B
| $52.5K | ﹤0.01% |
7,272
-34,022
| -82% | -$186K |
|
4563
Establishment Labs
ESTA
$2.24B
| $52.4K | ﹤0.01% |
1,228
+116
| +10% | +$4.04K |
|
4564
Gold Royalty Corp
GROY
$711M
| $52.4K | ﹤0.01% |
+23,730
| New | +$41.6K |
|
4565
Atomera
ATOM
$210M
| $52.4K | ﹤0.01% |
10,391
+9,895
| +1,995% | +$52.8K |
|
|
IGA
4566
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
| $51.9K | ﹤0.01% |
5,228
+57
| +1% | +$557 |
|
4567
Bel Fuse Inc Class A
BELFA
$3.29B
| $51.7K | ﹤0.01% |
575
-633
| -52% | -$43.9K |
|
4568
Monopar Therapeutics
MNPR
$779M
| $51.6K | ﹤0.01% |
1,443
+1,218
| +541% | +$44.2K |
|
4569
OP Bancorp
OPBK
$233M
| $51.6K | ﹤0.01% |
3,974
-7,839
| -66% | -$95.6K |
|
|
TRUE
4570
DELISTED
TrueCar
TRUE
| $51.5K | ﹤0.01% |
27,099
-30,380
| -53% | -$46.4K |
|
4571
iShares MSCI France ETF
EWQ
$334M
| $51.2K | ﹤0.01% |
1,197
-789
| -40% | -$32.6K |
|
4572
BCB Bancorp
BCBP
$155M
| $51.2K | ﹤0.01% |
6,082
-6,097
| -50% | -$51.7K |
|
4573
First National Corp
FXNC
$282M
| $51.1K | ﹤0.01% |
2,624
-4,197
| -62% | -$83K |
|
4574
Taboola.com
TBLA
$1.12B
| $50.9K | ﹤0.01% |
13,903
-1,541
| -10% | -$5.03K |
|
4575
iShares US Small Cap Equity Factor ETF
SMLF
$4.28B
| $50.8K | ﹤0.01% |
+748
| New | +$47.3K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.